Biliary Cancer Clinical Trials (Cholangiocarcinoma)

California Pacific CURRENTS: The online journal of CPMC Research Institute

Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma

Description: This randomized phase III trial studies how well gemcitabine hydrochloride and cisplatin with or without radiation therapy work in treating patients with localized liver cancer that cannot be removed by surgery

Investigators

  • NCI - National Cancer Institute

Eligibility Requirements

Subjects, 18 y/o and older, with a pathologically (histologically or cytologically) proven diagnosis of intrahepatic cholangiocarcinoma (IHC) without distant extrahepatic metastasis within 30 days of registration

Status

Please contact site for study status

Contacts

Peter Gasper, 415-600-3472

 

A Phase 2, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed or Are Intolerant to Platinum-Based Chemotherapy

Description: This is an open-label, monotherapy study of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocations, with other FGF/FGFR alterations, or who are negative for FGF/FGFR alterations

Investigators

Eligibility Requirements

Subjects, 18 y/o and older, with a histologically or cytologically confirmed cholangiocarcinoma

Status

Coming soon

Contacts

Brenda Eng, 415-600-1775